20 results
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
before initiating clinical trials involving humans. Animal testing activities have been the subject of controversy and adverse publicity. Animal rights
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
trials involving humans. Animal testing activities have been the subject of controversy and adverse publicity. Animal rights groups and other
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
initiating clinical trials involving humans. Animal testing activities have been the subject of controversy and adverse publicity. Animal rights groups
S-1/A
EX-1.1
62i5j xog6i
11 Sep 23
IPO registration (amended)
6:07am
S-1
EX-10.14
alf8oc bor92af
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.1
fg1l 5uluto8exjb2d4b
25 Aug 23
IPO registration
5:03pm
S-1
a4h u1lw6i19p2de
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.2
3em6yd72nv7vcl3j 1nz
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.1
aiq71e18nx2 wh8ywi4
25 Aug 23
IPO registration
5:03pm
DRS/A
j9jc2sdz bi2o
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
y2posg91az2rue25bid
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
EX-10.1
f5qk6x6
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
mjwomi gh7prd1st5c
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
dwlhg6p9dm2wocj
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
1csfv2dg
10 Jun 22
Draft registration statement (amended)
12:00am
DRS/A
hicp jii6jd0h
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
k03wn3ig yp
23 Dec 21
Draft registration statement (amended)
12:00am
DRS
rgvedv
8 Nov 21
Draft registration statement
12:00am
- Prev
- 1
- Next